glp 1 agonist natural America's Poison Centers GLP-1 Drugs and Eating Disorders:

144 A meta-analysis indicated that the use of DPP4 inhibitors was associated with a similar risk of infections, including respiratory diseases, compared to control groups

The cellular density of L-cells gradually increases along the length of the small intestine, with the lowest density in the duodenum and the highest in the distal ileum [1]

Dhir G, Cusi K (2018) Glucagon like peptide-1 receptor agonists for the management of obesity and nonalcoholic fatty liver disease: a novel therapeutic option

7,8,15 These results also align with Azzam et al

Wilmington, DE: AstraZeneca Pharmaceuticals LP;2019

MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed